The disclosure provides methods for the treatment of skin disorders through the use of minimally invasive terahertz radiation. The method includes exposing skin cells to terahertz radiation in amount sufficient to modulate gene expression in the skin cells. The modulation of gene expression then results in a reduction of the disease state or aspects thereof in the exposed skin cells.
